|
gptkbp:instanceOf
|
gptkb:brand
gptkb:antibiotic
|
|
gptkbp:activeIngredient
|
gptkb:moxifloxacin
|
|
gptkbp:approvedBy
|
gptkb:FDA
gptkb:EMA
1999
|
|
gptkbp:ATCCode
|
gptkb:J01MA14
|
|
gptkbp:brand
|
gptkb:moxifloxacin
|
|
gptkbp:CASNumber
|
gptkb:151096-09-2
|
|
gptkbp:chemicalFormula
|
gptkb:C21H24FN3O4
|
|
gptkbp:contraindication
|
hypersensitivity to moxifloxacin
history of tendon disorders related to fluoroquinolones
|
|
gptkbp:drugClass
|
fluoroquinolone
|
|
gptkbp:eliminationHalfLife
|
12 hours
|
|
gptkbp:excretion
|
urine
feces
|
|
gptkbp:genericName
|
gptkb:moxifloxacin
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Avelox
|
|
gptkbp:interactsWith
|
gptkb:warfarin
gptkb:NSAIDs
antacids
antiarrhythmic drugs
|
|
gptkbp:legalStatus
|
prescription only
|
|
gptkbp:manufacturer
|
gptkb:Bayer
|
|
gptkbp:metabolism
|
liver
|
|
gptkbp:notRecommendedFor
|
children
pregnant women
breastfeeding women
|
|
gptkbp:pregnancyCategory
|
C (US)
B3 (Australia)
|
|
gptkbp:prescribes
|
adults
|
|
gptkbp:riskFactor
|
peripheral neuropathy
hypersensitivity reactions
CNS effects
tendon rupture
|
|
gptkbp:routeOfAdministration
|
oral
intravenous
|
|
gptkbp:sideEffect
|
nausea
diarrhea
dizziness
headache
QT prolongation
|
|
gptkbp:usedFor
|
gptkb:sinusitis
skin infections
bacterial infections
respiratory tract infections
community-acquired pneumonia
|
|
gptkbp:bfsParent
|
gptkb:Merck_&_Co.
|
|
gptkbp:bfsLayer
|
4
|